Provided by Tiger Trade Technology Pte. Ltd.

Terns Pharmaceuticals, Inc.

41.38
-0.0700-0.17%
Post-market: 41.400.0200+0.05%17:06 EST
Volume:2.27M
Turnover:94.06M
Market Cap:4.51B
PE:-40.10
High:42.13
Open:41.15
Low:40.84
Close:41.45
52wk High:48.26
52wk Low:1.87
Shares:109.00M
Float Shares:80.32M
Volume Ratio:1.56
T/O Rate:2.82%
Dividend:- -
Dividend Rate:- -
EPS(TTM):-1.0319
EPS(LYR):-1.1175
ROE:-29.12%
ROA:-19.94%
PB:15.88
PE(LYR):-37.03

Loading ...

Terns Pharmaceuticals Reports Positive Data on Leukemia Drug

Dow Jones
·
Dec 09, 2025

Terns Pharmaceuticals Shares Rise in Volume Spike, Last up 11.7% at $32.79

THOMSON REUTERS
·
Dec 09, 2025

Terns Pharmaceuticals Reports Positive Phase 1 Results for TERN-701 in Relapsed CML

Reuters
·
Dec 09, 2025

Terns Highlights Additional Positive Phase 1 Clinical Data Supporting TERN-701’s Best-in-Disease Potential in Relapsed/Refractory CML at the 67th ASH Annual Meeting

GlobeNewswire
·
Dec 09, 2025

NASDAQ TRADE HALT HALT NEWS PENDING AT 02:40 PM

Reuters
·
Dec 09, 2025

Analysts Conflicted on These Healthcare Names: Terns Pharmaceuticals (TERN) and Ironwood Pharma (IRWD)

TIPRANKS
·
Nov 26, 2025

Terns Pharmaceuticals price target raised to $35 from $25 at Citizens JMP

TIPRANKS
·
Nov 26, 2025

Terns Pharmaceuticals Is Maintained at Overweight by Barclays

Dow Jones
·
Nov 25, 2025

Barclays Reaffirms Their Buy Rating on Terns Pharmaceuticals (TERN)

TIPRANKS
·
Nov 25, 2025

Promising Outlook for TERN-701 in CML Market: Buy Rating Affirmed by Analyst

TIPRANKS
·
Nov 20, 2025

Terns Pharmaceuticals Is Maintained at Buy by Truist Securities

Dow Jones
·
Nov 20, 2025

Terns Pharmaceuticals Q3 Net Income USD -24.635 Million Vs. IBES Estimate USD -27.2 Million

Reuters
·
Nov 20, 2025

Terns Pharmaceuticals (TERN) Gets a Buy from Truist Financial

TIPRANKS
·
Nov 19, 2025

Truist Raises Price Target on Terns Pharmaceuticals to $35 From $28, Keeps Buy Rating

MT Newswires Live
·
Nov 19, 2025

U.S. RESEARCH ROUNDUP-Amgen, Crowdstrike, Micron Technology

Reuters
·
Nov 19, 2025

Terns Pharmaceuticals Inc : Truist Securities Raises Target Price to $35 From $28

THOMSON REUTERS
·
Nov 19, 2025

Terns Pharmaceuticals Is Maintained at Outperform by BMO Capital

Dow Jones
·
Nov 19, 2025

Could Terns Pharmaceuticals' (TERN) Increased Conference Visibility Reflect a Shift in Management Strategy?

Simply Wall St.
·
Nov 18, 2025

Terns Pharmaceuticals price target raised to $30 from $22 at BMO Capital

TIPRANKS
·
Nov 18, 2025

A Fresh Look at Terns Pharmaceuticals (TERN) Valuation Following New CARDINAL Trial Results and ASH Presentation

Simply Wall St.
·
Nov 15, 2025